v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 252,721 $ 233,351
Accounts receivable, net 31,738 23,928
Inventory 11,614 1,404
Other receivables - related party 947 744
Prepaid expenses and other current assets 4,167 6,723
Total current assets 301,187 266,150
Property and equipment, net 13,975 11,923
Operating lease right-of-use asset, net 19,415 20,487
Restricted cash 1,645 1,645
Long-term investment, at fair value 56,860 17,566
Intangible asset, net 13,043 14,629
Other assets 1,708 1,013
Total assets 407,833 333,413
Current liabilities    
Accounts payable and accrued expenses 82,855 45,389
Accounts payable - related party 74 0
Deferred revenue 3,354 0
Operating lease liabilities, short-term 2,047 1,849
Notes payable, short-term 10,450 0
Partner company installment payments - licenses, short-term (net of imputed interest of $567 and $778 as of September 30, 2021 and December 31, 2020, respectively) 4,433 4,522
Total current liabilities 103,213 51,760
Notes payable, long-term (net of debt discount of $7,431 and $8,323 as of September 30, 2021 and December 31, 2020, respectively) 42,569 51,677
Operating lease liabilities, long-term 21,522 22,891
Partner company installment payments - licenses, long-term (net of imputed interest of $461 and $863 as of September 30, 2021 and December 31, 2020, respectively) 3,539 8,137
Partner company convertible preferred shares, short-term (net of debt discount of $1,923 as of September 30, 2021 ) 18,078 0
Partner company derivative warrant liabilities 4,365 0
Other long-term liabilities 2,079 1,949
Total liabilities 195,365 136,414
Commitments and contingencies (Note 16)
Stockholders' equity    
Cumulative redeemable perpetual preferred stock, $.001 par value, 15,000,000 authorized, 5,000,000 designated Series A shares, 3,427,138 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively, liquidation value of $25.00 per share 3 3
Common stock, $.001 par value, 170,000,000 shares authorized, 98,714,222 shares issued and outstanding as of September 30, 2021; 150,000,000 shares authorized, 94,877,492 shares issued and outstanding as of December 31, 2020, respectively 99 95
Common stock issuable, 116,866 and 0 shares as of September 30, 2021 and December 31, 2020,respectively 365 0
Additional paid-in-capital 608,089 583,000
Accumulated deficit (515,898) (482,760)
Total stockholders' equity attributed to the Company 92,658 100,338
Non-controlling interests 119,810 96,661
Total stockholders' equity 212,468 196,999
Total liabilities and stockholders' equity $ 407,833 $ 333,413

Source